Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:30:37 +0200Tue, 09 Apr 2024 16:54:00 +0200Human medicines European public assessment report (EPAR): Ninlaro, ixazomib, Date of authorisation: 21/11/2016, Revision: 18, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ninlaroHuman medicines European public assessment report (EPAR): Ninlaro, ixazomib, Date of authorisation: 21/11/2016, Revision: 18, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ninlaroTue, 09 Apr 2024 16:54:00 +0200Human medicineNinlaro : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-3844-steps-after_en_0.pdfNinlaro : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-3844-steps-after_en_0.pdfTue, 09 Apr 2024 16:37:00 +0200Human medicine